Showing results (171-180 of 249) with videos related to

Sort By:
Pageof 25
Advances in Experimental Medicine and Biology|August 24, 2007
Role of altered expression of HLA class I molecules in cancer progressionNatalia Aptsiauri, Teresa Cabrera, Rosa Mendez, et al.
Cancer Immunology, Immunotherapy : CII|January 22, 2003
Analysis of HLA expression in human tumor tissuesTeresa Cabrera, Miguel Angel López-Nevot, Jose Juan Gaforio, et al.
Anais Da Academia Brasileira De Ciencias|December 6, 2023
Scientific production in biodiversity: the gender gap continues in Brazilian universitiesFederico Garrido-DE León, Jair H Castro Romero, Michel V Garey, et al.
Current Opinion in Immunology|January 23, 2016
The urgent need to recover MHC class I in cancers for effective immunotherapyFederico Garrido, Natalia Aptsiauri, Elien M Doorduijn, et al.
Cancer Immunology, Immunotherapy : CII|May 21, 2008
Regressing and progressing metastatic lesions: resistance to immunotherapy is predetermined by irreversible HLA class I antigen alterationsNatalia Aptsiauri, Rafael Carretero, Angel Garcia-Lora, et al.
Vaccines|March 8, 2017
The Escape of Cancer from T Cell-Mediated Immune Surveillance: HLA Class I Loss and Tumor Tissue ArchitectureFederico Garrido, Francisco Perea, Mónica Bernal, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 3, 2014
Antibody stabilization of peptide-MHC multimers reveals functional T cells bearing extremely low-affinity TCRsKatie Tungatt, Valentina Bianchi, Michael D Crowther, et al.
Frontiers in Immunology|August 22, 2022
Corrigendum: Patients with myeloproliferative neoplasms harbor high frequencies of CD8 T cell-platelet aggregates associated with T cell suppressionAna Micaela Carnaz Simões, Morten Orebo Holmström, Pia Aehnlich, et al.
Iscience|August 3, 2023
Galectin-1 induces a tumor-associated macrophage phenotype and upregulates indoleamine 2,3-dioxygenase-1Asha M Rudjord-Levann, Zilu Ye, Lise Hafkenscheid, et al.
Pageof 25